AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patient-reported Outcome and Patient-reported Experience After Status Epilepticus

Recruitingn/aAges 18 Years - anyAllVersailles Hospital
💬

In plain words

What the trial is, and whether it could suit you

Status epilepticus (SE) is a common life-threatening neurological emergency in which prolonged or multiple closely spaced seizures can result in long-term impairments. SE remains associated with considerable mortality and morbidity, with little progress over the last three decades. The proportion of patients who die in the hospital is about 20% overall and 40% in patients with refractory SE. Morbidity is more difficult to evaluate, as adverse effects of SE are often difficult to differentiate from those attributed to the cause of SE. Our experience suggests that nearly 50% of patients may experience long-term functional impairments. The precise description of the consequences of these functional impairments and their impact on quality of life after SE requiring intensive care management has been little studied. Indeed, if cognitive, physical and mental impairments are now identified in t

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Adults 18 years old or older * Patients previously included in the ICTAL registry (Status Epilepticus cohort NCT03457831) * Survivors after ICU management for Status Epilepticus More than 3 months and less than 5 years after ICU discharge Exclusion Criteria: * Legal guardianship * Opposition to participate * Unread and unwritten French language * Patient not affiliated to a Social Security system
💊

What it tests

  • Not listed
📍

Where

19 sites
CH d'Angoulême
Angoulême, France
CH d'Arras
Arras, France
CHU de Besançon
Besançon, France
CH de Béthune
Béthune, France
CHU de Brest
Brest, France
CH de Cannes
Cannes, France
Hôpital Beaujon
Clichy, France
Hôpital Henri Mondor
Créteil, France

…and 11 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy